Hospira Methotrexate Injection USP 50 mg/2 mL vial

Χώρα: Αυστραλία

Γλώσσα: Αγγλικά

Πηγή: Department of Health (Therapeutic Goods Administration)

Δραστική ουσία:

sodium chloride, Quantity: 2.6 mg/mL; methotrexate, Quantity: 25 mg/mL

Διαθέσιμο από:

Hospira Australia Pty Ltd

INN (Διεθνής Όνομα):

Methotrexate,sodium chloride

Φαρμακοτεχνική μορφή:

Injection

Σύνθεση:

Excipient Ingredients: benzyl alcohol; sodium hydroxide; water for injections; hydrochloric acid

Οδός χορήγησης:

Intraarterial, Intravenous, Intramuscular

Μονάδες σε πακέτο:

5 x 2 mL vials

Kατηγορία:

Medicine Listed (Export Only)

Τρόπος διάθεσης:

(S1) This Schedule is intentionally blank

Θεραπευτικές ενδείξεις:

Methotrexate Injection USP belongs to a group of medicines known as anti-metabolites. It is used in high doses to treat certain types of cancers, including breast cancer, Non-Hodgkin's lymphoma and leukemia. At lower doses, it may also be used to treat severe psoriasis and severe rheumatoid arthritis.

Περίληψη προϊόντος:

Visual Identification: A yellow solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 30 Months; Container Temperature: Store between 15-25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Καθεστώς αδειοδότησης:

Licence status A

Ημερομηνία της άδειας:

2007-09-13